CVS NYSE Week ended 24 Jul 2026

Weekly Investor Report

CVS Health Corp · Healthcare · Healthcare Plans

Open interactive chart View report data Download investor PDF
Latest close 107.7 USD
0.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 25.5% above the Trend Line and sits at 95.7% of its 52-week range. The latest completed week returned 0.9%, after a 3.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 51/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 0d.

Setup score 72 out of 100
Latest Close 107.7 USD 24 Jul 2026
1W Return 0.9% latest completed week
4W Return 3.9% short-term follow-through
12W Return 31.2% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 12-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.9% Latest completed week; four-week move 3.9%. Indicator stack 88/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 51/100 conviction; expected move 3.1%. News sentiment 55/100 41 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 25.5% above the Trend Line and sits at 95.7% of its 52-week range. The latest completed week returned 0.9%, after a 3.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9912-week average 0.79

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.99Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.9% over four weeks, 31.2% over 12 weeks, and 81.9% over one year. The current trend has remained active for 12 consecutive weeks.

Performance by holding period

1W0.9%
4W3.9%
12W31.2%
26W30.9%
52W81.9%
Active trend streak12 weeks
Active weeks in one year44
Trend breadth84.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.26Latest activity-pressure read.
Pressure change-3.8%Four-week change in activity pressure.
Leadership23.87Latest relative-leadership reading.
RS change-1.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value25/100Relative valuation strength. Underlying universe rank 76; rank 1 is best.
Quality21/100Profitability and accounting quality. Underlying universe rank 80; rank 1 is best.
Momentum92/100Medium-term price momentum. Underlying universe rank 9; rank 1 is best.
Growth4/100Revenue and earnings growth. Underlying universe rank 97; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework32/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
46.9x
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
18.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
13.9%
Gross profit retained from each unit of revenue.
Operating margin
1.6%
Operating profit retained from revenue.
Free-cash-flow margin
3.3%
Free cash flow generated from revenue.
Return on invested capital
3.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.6%
Latest one-year revenue growth.
EPS growth
-44.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
14.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.5%
Cash dividends relative to market value.
Buyback yield
-0.3%
Net share repurchases relative to market value.
Shareholder yield
2.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
6.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

CVS shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.17, expected move of 3.1%, and Sharemaestro trend signal active.

Conviction51/100
Expected move3.1%
Put/call volume0.17
Pressure72
Speculation41
Volatility41
Trend agreement29
Open options detail
Insider activity7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 41 relevant articles.

15 positive · 25 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
Options expected move3.1%Nearest-chain priced movement where available.
52-week drawdown-2.1%Distance below the 52-week high.
13-week volatility4.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+10.3%Week of 8 May.
Worst week-10.2%Week of 30 Jan.
Latest week+0.9%Week of 24 Jul.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks0
Modest losses8
Sharp losses3
Recent vol4.2%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split35/17Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape72/100

Trend, activity pressure, participation, and risk combine to a 72/100 tape read.

 Indicator analysis87/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.99; 2 reversal markers Factors39/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 74 SVQF32/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 690.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options55/100

CVS shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.17, expected move of 3.1%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 3.1% Sentiment55/100

Weighted news tone is neutral across 41 relevant articles.

CVS asks federal judge to consolidate four lawsuits challenging Tennessee PBM breakup law Insiders7 / 13

7 acquisitions and 13 disposals in the latest 180-day insider tape.

 Earnings0d

Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.

 Research flow2 items

2 recent research articles and 0 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026107.7 USD0.9%85.85 USD67.01 USD1.2623.8737.2MOn
17 Jul 2026106.8 USD3.2%84.87 USD66.75 USD1.2923.1244.2MOn
10 Jul 2026103.5 USD-0.5%83.86 USD66.50 USD1.1918.4033.3MOn
3 Jul 2026104.1 USD0.4%83.02 USD66.24 USD1.2821.3923.4MOn
26 Jun 2026103.7 USD6.1%82.03 USD65.97 USD1.3124.2943.3MOn
19 Jun 202697.71 USD-4.2%81.20 USD65.70 USD1.1414.9840.1MOn
12 Jun 2026102.0 USD6.3%80.51 USD65.47 USD1.1921.5446.3MOn
5 Jun 202695.93 USD5.4%79.66 USD65.20 USD1.2115.5340.4MOn
29 May 202690.98 USD-2.4%79.05 USD65.00 USD1.287.3127.7MOn
22 May 202693.26 USD-2.7%78.58 USD64.81 USD1.1411.8739.3MOn
15 May 202695.89 USD5.9%78.16 USD64.60 USD0.7316.4955.5MOn
8 May 202690.55 USD10.3%77.65 USD64.38 USD0.1710.7548.4MOn
1 May 202682.09 USD5.3%77.16 USD64.20 USD-0.302.8934.9MOff
24 Apr 202677.94 USD1.7%76.95 USD64.07 USD-0.69-1.4336.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.